+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 80Years
All Genders
ID07830576

Developing a Survival Prediction Model Using 3D MRI and Clinical Data for Patients After Colorectal Liver Metastases Surgery

Led by Anhui Provincial Hospital · Updated on 2026-09-21

205

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are developing and validating a survival prediction model for patients with colorectal liver metastases who have undergone surgery. This model combines detailed imaging features from preoperative 3D MRI scans with clinical baseline indicators like liver function and tumor biomarkers. The goal is to assess individual post-operative risks more accurately and help clinicians tailor follow-up care and personalized treatment plans. The study uses advanced machine learning to analyze 3D regions of interest from MRI scans, capturing tumor micro-heterogeneity and invasive characteristics. These imaging features are integrated with clinical data to build a visual predictive tool called a nomogram. The models performance will be evaluated over time and validated using an external patient group to ensure reliability and generalizability. Participants have undergone surgical resection for colorectal liver metastases and had preoperative MRI scans. Researchers will collect baseline clinical and laboratory data as well as follow-up information on recurrence-free survival for up to five years after surgery. No experimental treatments are assigned instead, this is an observational study using imaging and clinical data to develop and test the prediction model.

CONDITIONS

Brief Title

Multimodal Survival Prediction Model for Colorectal Liver Metastases Post-Operation

Research Team

C

can zhang

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here